Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations

J Clin Endocrinol Metab. 1999 Jan;84(1):378-81. doi: 10.1210/jcem.84.1.5554.


Congenital adrenal hyperplasia (CAH) owing to 21-hydroxylase deficiency (21-OHD) is the most common inherited defect of adrenal steroid biosynthesis. At least 36 mutations in the CYP21 gene, which is mapped to chromosome 6p21.3, have been described. We performed genetic analysis of the CYP21 gene in a patient with classic 21-OHD CAH and her family. The entire exonic coding regions and intronic regions, as well as the -1 kb 5' upstream promoter region, were thoroughly sequenced and analyzed. Despite extensive sequencing, no mutation was found in this 3.7 kb area. The 11beta-hydroxylase defect, closely mimicking the clinical and biochemical phenotype of classic 21-OHD, was excluded by directly sequencing 2.6 kb covering the entire coding of the CYP11B1 gene. Herein we describe a phenotypically and hormonally affected patient with classic simple virilizing 21-OHD CAH who lacks a mutation in the entire CYP21 gene and coding region of the CYP11B1 gene.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenal Hyperplasia, Congenital / genetics*
  • Adrenocorticotropic Hormone / pharmacology
  • Child, Preschool
  • Female
  • Humans
  • Mutation*
  • Steroid 11-beta-Hydroxylase / genetics
  • Steroid 21-Hydroxylase / genetics*


  • Adrenocorticotropic Hormone
  • Steroid 21-Hydroxylase
  • Steroid 11-beta-Hydroxylase